Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

HST Global Gross Profit 2010-2023 | HSTC

HST Global gross profit from 2010 to 2023. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  
HST Global Annual Gross Profit
(Millions of US $)
2023 $
2022 $
2021 $
2020 $
2019 $
2018 $
2017 $
2016 $
2015 $
2014 $
2013 $
2012 $
2011 $
2010 $
2009 $
HST Global Quarterly Gross Profit
(Millions of US $)
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.000B $0.000B
HST GLOBAL, INC., formerly NT Holding Corp., is in the business of developing drugs to combat cancer. HSTI is a development-stage biopharmaceutical company that acquires and develops products for the treatment of cancer. The Company has focused on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer, and then developing those drug candidates for commercial use. The Company has entered into a letter of intent for the rights to one clinical stage drug candidate: Salicinium. Salicinium is an oral and parental active inhibitor. Clinical studies demonstrate that Salicinium alters malignant cell fermentation dynamics, blocks cell division (mitosis) and causes fermenting (cancer) cells' loss of ability to withstand the innate immune reactions.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.484B 31.03
Chugai Pharmaceutical (CHGCY) Japan $54.153B 24.21
Takeda Pharmaceutical (TAK) Japan $41.997B 6.81
Merck (MKGAF) Germany $20.937B 19.76
Astellas Pharma (ALPMY) Japan $18.042B 28.49
Sandoz Group AG (SDZNY) Switzerland $14.632B 0.00
Shionogi (SGIOY) Japan $14.080B 12.63
Neurocrine Biosciences (NBIX) United States $14.072B 38.52
United Therapeutics (UTHR) United States $11.452B 12.20
Catalent (CTLT) United States $10.196B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.733B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.890B 7.57
Revolution Medicines (RVMD) United States $6.682B 0.00
Ionis Pharmaceuticals (IONS) United States $6.280B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.918B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.599B 0.00
Alpine Immune Sciences (ALPN) United States $4.235B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.684B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.990B 0.00
Summit Therapeutics (SMMT) United States $2.850B 0.00
Corcept Therapeutics (CORT) United States $2.609B 23.64
PTC Therapeutics (PTCT) United States $2.579B 0.00
Indivior (INDV) United States $2.472B 11.72
Dyne Therapeutics (DYN) United States $2.241B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.063B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.015B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.907B 11.29
Evotec AG (EVO) Germany $1.903B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.824B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.773B 18.32
Avadel Pharmaceuticals (AVDL) Ireland $1.658B 0.00
Soleno Therapeutics (SLNO) United States $1.645B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.598B 27.97
Ardelyx (ARDX) United States $1.589B 0.00
Xencor (XNCR) United States $1.457B 0.00
4D Molecular Therapeutics (FDMT) United States $1.350B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.299B 12.21
Pacira BioSciences (PCRX) United States $1.271B 12.65
Collegium Pharmaceutical (COLL) United States $1.227B 7.55
Cronos Group (CRON) Canada $1.016B 0.00
Enliven Therapeutics (ELVN) United States $0.987B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.958B 0.00
Cassava Sciences (SAVA) United States $0.954B 0.00
Relay Therapeutics (RLAY) United States $0.937B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.924B 0.00
ARS Pharmaceuticals (SPRY) United States $0.917B 0.00
Ocular Therapeutix (OCUL) United States $0.908B 0.00
USANA Health Sciences (USNA) United States $0.906B 14.67
Sage Therapeutics (SAGE) United States $0.789B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.739B 0.00
Siga Technologies (SIGA) United States $0.671B 9.94
Savara (SVRA) United States $0.647B 0.00
Silence Therapeutics (SLN) United Kingdom $0.637B 0.00
Exscientia (EXAI) United Kingdom $0.615B 0.00
Lyell Immunopharma (LYEL) United States $0.612B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.566B 0.00
OmniAb (OABI) United States $0.539B 0.00
Verve Therapeutics (VERV) United States $0.516B 0.00
KalVista Pharmaceuticals (KALV) United States $0.513B 0.00
Altimmune (ALT) United States $0.510B 0.00
ProKidney (PROK) United States $0.493B 0.00
Larimar Therapeutics (LRMR) United States $0.486B 0.00
Korro Bio (KRRO) United States $0.467B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.455B 0.00
Lexeo Therapeutics (LXEO) United States $0.411B 0.00
Tourmaline Bio (TRML) United States $0.408B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.401B 0.00
Esperion Therapeutics (ESPR) United States $0.390B 0.00
Heron Therapeutics (HRTX) United States $0.384B 0.00
Harrow (HROW) United States $0.376B 0.00
Nature's Sunshine Products (NATR) United States $0.365B 20.40
Black Diamond Therapeutics (BDTX) United States $0.346B 0.00
Organogenesis (ORGO) United States $0.329B 62.25
Bioventus (BVS) United States $0.314B 0.00
Fractyl Health (GUTS) United States $0.312B 0.00
ESSA Pharma (EPIX) Canada $0.307B 0.00
Nektar Therapeutics (NKTR) United States $0.307B 0.00
Aquestive Therapeutics (AQST) United States $0.299B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.294B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.287B 0.00
Nanobiotix S.A (NBTX) France $0.285B 0.00
Lyra Therapeutics (LYRA) United States $0.282B 0.00
Xeris Biopharma Holdings (XERS) United States $0.276B 0.00
Akebia Therapeutics (AKBA) United States $0.272B 0.00
Foghorn Therapeutics (FHTX) United States $0.260B 0.00
Pyxis Oncology (PYXS) United States $0.260B 0.00
Aldeyra Therapeutics (ALDX) United States $0.250B 0.00
Adherex Technologies (FENC) United States $0.248B 0.00
Eliem Therapeutics (ELYM) United States $0.233B 0.00
Metagenomi (MGX) United States $0.231B 0.00
Avita Medical (RCEL) United States $0.225B 0.00
Conduit Pharmaceuticals (CDT) United States $0.221B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Galectin Therapeutics (GALT) United States $0.209B 0.00
Zevra Therapeutics (ZVRA) United States $0.206B 0.00
Telomir Pharmaceuticals (TELO) United States $0.203B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.202B 0.00
Century Therapeutics (IPSC) United States $0.194B 0.00
Acrivon Therapeutics (ACRV) United States $0.192B 0.00
Profound Medical (PROF) Canada $0.180B 0.00
MediWound (MDWD) Israel $0.179B 0.00
Regulus Therapeutics (RGLS) United States $0.176B 0.00
Prelude Therapeutics (PRLD) United States $0.168B 0.00
Incannex Healthcare (IXHL) Australia $0.162B 0.00
Achieve Life Sciences (ACHV) Canada $0.161B 0.00
Elite Pharmaceuticals (ELTP) United States $0.138B 12.92
CytoDyn (CYDY) United States $0.138B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.136B 2.86
Cardiol Therapeutics (CRDL) Canada $0.135B 0.00
VAXART, INC (VXRT) United States $0.132B 0.00
Karyopharm Therapeutics (KPTI) United States $0.126B 0.00
Citius Pharmaceuticals (CTXR) United States $0.112B 0.00
FibroGen (FGEN) United States $0.112B 0.00
Relmada Therapeutics (RLMD) United States $0.112B 0.00
GlycoMimetics (GLYC) United States $0.111B 0.00
Inotiv (NOTV) United States $0.107B 0.00
OptiNose (OPTN) United States $0.099B 0.00
PMV Pharmaceuticals (PMVP) United States $0.096B 0.00
Assertio Holdings (ASRT) United States $0.096B 7.77
ProPhase Labs (PRPH) United States $0.096B 0.00
Vivani Medical (VANI) United States $0.095B 0.00
Aclaris Therapeutics (ACRS) United States $0.093B 0.00
AlloVir (ALVR) United States $0.093B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.089B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Jaguar Animal Health (JAGX) United States $0.081B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.080B 0.00
Tempest Therapeutics (TPST) United States $0.079B 0.00
Journey Medical (DERM) United States $0.072B 0.00
SCYNEXIS (SCYX) United States $0.067B 1.00
Carisma Therapeutics (CARM) United States $0.066B 0.00
Champions Oncology (CSBR) United States $0.066B 0.00
Mural Oncology (MURA) Ireland $0.065B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.058B 0.00
Gain Therapeutics (GANX) United States $0.053B 0.00
BioLineRx (BLRX) Israel $0.053B 0.00
Unicycive Therapeutics (UNCY) United States $0.042B 0.00
Rafael Holdings (RFL) United States $0.040B 0.00
Natural Alternatives (NAII) United States $0.038B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
CASI Pharmaceuticals (CASI) China $0.036B 0.00
VYNE Therapeutics (VYNE) United States $0.035B 0.00
JanOne (JAN) United States $0.034B 0.00
Protara Therapeutics (TARA) United States $0.033B 0.00
Viracta Therapeutics (VIRX) United States $0.033B 0.00
Surrozen (SRZN) United States $0.032B 0.00
DURECT (DRRX) United States $0.031B 0.00
Enlivex Therapeutics (ENLV) Israel $0.030B 0.00
Nutriband (NTRB) United States $0.029B 0.00
Iterum Therapeutics (ITRM) Ireland $0.026B 0.00
Oncternal Therapeutics (ONCT) United States $0.026B 0.00
Lipocine (LPCN) United States $0.025B 0.00
PolyPid (PYPD) Israel $0.023B 0.00
TherapeuticsMD (TXMD) United States $0.022B 0.00
Alaunos Therapeutics (TCRT) United States $0.022B 0.00
NRx Pharmaceuticals (NRXP) United States $0.022B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.021B 10.07
MEI Pharma (MEIP) United States $0.020B 1.03
CERo Therapeutics Holdings (CERO) United States $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
Aptorum Group (APM) United Kingdom $0.019B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Talphera (TLPH) United States $0.017B 0.00
Indaptus Therapeutics (INDP) United States $0.017B 0.00
Minerva Neurosciences (NERV) United States $0.016B 0.00
Traws Pharma (TRAW) United States $0.016B 0.00
Avalo Therapeutics (AVTX) United States $0.016B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
Dominari Holdings (DOMH) United States $0.013B 0.00
Cosmos Health (COSM) Greece $0.011B 0.00
Molecular Templates (MTEM) United States $0.011B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Inhibikase Therapeutics (IKT) United States $0.009B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.008B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.007B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
TransCode Therapeutics (RNAZ) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.004B 0.00
Clever Leaves Holdings (CLVR) Canada $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.71
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 43.24